Wells Fargo Co New (WFC) Holder Spectrum Management Group Has Increased Its Position by $2.27 Million; Valeant Pharmaceuticals Intl (Put) (VRX) Holding Has Raised by Pomelo Capital Llc

January 16, 2018 - By Ellis Scott

Spectrum Management Group Inc increased its stake in Wells Fargo Co New (WFC) by 431.64% based on its latest 2017Q3 regulatory filing with the SEC. Spectrum Management Group Inc bought 41,230 shares as the company’s stock declined 8.66% while stock markets rallied. The institutional investor held 50,782 shares of the major banks company at the end of 2017Q3, valued at $2.80 million, up from 9,552 at the end of the previous reported quarter. Spectrum Management Group Inc who had been investing in Wells Fargo Co New for a number of months, seems to be bullish on the $309.47B market cap company. The stock increased 0.47% or $0.2961 during the last trading session, reaching $62.8461. About 8.81 million shares traded. Wells Fargo & Company (NYSE:WFC) has risen 9.67% since January 16, 2017 and is uptrending. It has underperformed by 7.03% the S&P500.

Philip Rosenstrach increased its stake in Valeant Pharmaceuticals Intl (Put) (VRX) by 375.95% based on its latest 2017Q3 regulatory filing with the SEC. Pomelo Capital Llc bought 827,100 shares as the company’s stock declined 15.71% while stock markets rallied. The hedge fund run by Philip Rosenstrach held 1.05 million shares of the health care company at the end of 2017Q3, valued at $15.01 million, up from 220,000 at the end of the previous reported quarter. Pomelo Capital Llc who had been investing in Valeant Pharmaceuticals Intl (Put) for a number of months, seems to be bullish on the $8.20B market cap company. The stock decreased 1.30% or $0.31 during the last trading session, reaching $23.53. About 7.40 million shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has declined 48.51% since January 16, 2017 and is downtrending. It has underperformed by 65.21% the S&P500.

Spectrum Management Group Inc, which manages about $448.94M and $307.60 million US Long portfolio, decreased its stake in Vanguard Bd Index Fd Inc (BND) by 24,491 shares to 14,143 shares, valued at $1.16 million in 2017Q3, according to the filing. It also reduced its holding in Select Sector Spdr Tr (XLK) by 47,040 shares in the quarter, leaving it with 224,924 shares, and cut its stake in Tjx Cos Inc New (NYSE:TJX).

Investors sentiment decreased to 0.73 in Q3 2017. Its down 0.15, from 0.88 in 2017Q2. It dived, as 92 investors sold WFC shares while 725 reduced holdings. 103 funds opened positions while 495 raised stakes. 3.65 billion shares or 0.40% less from 3.66 billion shares in 2017Q2 were reported. Moreover, Blackrock Inc has 0.78% invested in Wells Fargo & Company (NYSE:WFC) for 279.75 million shares. Waddell And Reed has invested 0.62% in Wells Fargo & Company (NYSE:WFC). Highlander Capital Management Ltd Co stated it has 2,439 shares. 4.46M were accumulated by State Treasurer State Of Michigan. Wesbanco National Bank Incorporated accumulated 1.17% or 407,071 shares. Hengehold Management Lc reported 42,857 shares. Burke & Herbert Bancorp & Tru holds 1.22% of its portfolio in Wells Fargo & Company (NYSE:WFC) for 24,421 shares. Arcadia Investment Mi holds 0.16% or 9,287 shares. Vantage Investment Limited Com accumulated 6.30M shares or 27.06% of the stock. Bell Commercial Bank owns 0.18% invested in Wells Fargo & Company (NYSE:WFC) for 10,993 shares. Vision Mgmt owns 12,810 shares. Orca Invest Management Ltd Liability Corp reported 1.33% stake. Central Asset Investments & (Hk) has 4,000 shares. Garde Capital reported 0.23% of its portfolio in Wells Fargo & Company (NYSE:WFC). Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.83% or 1.62 million shares.

Among 36 analysts covering Wells Fargo & Company (NYSE:WFC), 17 have Buy rating, 5 Sell and 14 Hold. Therefore 47% are positive. Wells Fargo & Company had 117 analyst reports since July 29, 2015 according to SRatingsIntel. UBS maintained Wells Fargo & Company (NYSE:WFC) rating on Friday, October 6. UBS has “Neutral” rating and $57 target. On Thursday, December 21 the stock rating was maintained by Keefe Bruyette & Woods with “Buy”. The company was upgraded on Tuesday, September 8 by Evercore. The firm earned “Underweight” rating on Friday, April 15 by Piper Jaffray. Rafferty downgraded the shares of WFC in report on Wednesday, April 12 to “Sell” rating. UBS maintained the shares of WFC in report on Monday, October 16 with “Neutral” rating. The stock of Wells Fargo & Company (NYSE:WFC) has “Positive” rating given on Wednesday, January 20 by Susquehanna. The company was maintained on Wednesday, April 19 by Evercore. The firm has “Buy” rating by Deutsche Bank given on Tuesday, September 8. The company was maintained on Wednesday, April 12 by Sandler O’Neill.

Among 27 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 6 have Buy rating, 5 Sell and 16 Hold. Therefore 22% are positive. Valeant Pharmaceuticals Intl had 148 analyst reports since July 21, 2015 according to SRatingsIntel. On Monday, September 18 the stock rating was maintained by H.C. Wainwright with “Hold”. The firm earned “Underperform” rating on Friday, February 19 by Wells Fargo. Cantor Fitzgerald maintained it with “Buy” rating and $2300 target in Friday, July 28 report. Jefferies maintained the shares of VRX in report on Friday, June 9 with “Buy” rating. The stock of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) earned “Buy” rating by Cantor Fitzgerald on Tuesday, November 7. As per Monday, October 2, the company rating was maintained by Cantor Fitzgerald. The firm has “Sector Perform” rating given on Tuesday, February 14 by RBC Capital Markets. The rating was maintained by Jefferies with “Buy” on Wednesday, June 8. The stock of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has “Hold” rating given on Tuesday, August 8 by BTIG Research. The firm has “Neutral” rating by Mizuho given on Thursday, January 7.

Pomelo Capital Llc, which manages about $366.34 million and $2.35 billion US Long portfolio, decreased its stake in Chesapeake Energy Corp (NYSE:CHK) by 509,900 shares to 760,500 shares, valued at $3.27M in 2017Q3, according to the filing. It also reduced its holding in Freeport (NYSE:FCX) by 4.89M shares in the quarter, leaving it with 100,000 shares, and cut its stake in Gamestop Corp New (NYSE:GME).

Investors sentiment decreased to 0.99 in Q3 2017. Its down 0.09, from 1.08 in 2017Q2. It dived, as 43 investors sold VRX shares while 68 reduced holdings. 27 funds opened positions while 83 raised stakes. 169.87 million shares or 1.18% less from 171.89 million shares in 2017Q2 were reported. Barclays Public Limited Com reported 1.84M shares. Envestnet Asset Mgmt Incorporated holds 1,483 shares. Gotham Asset Management Limited Liability has invested 0.1% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Amer Century Cos has invested 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Manufacturers Life Insur Com The holds 0.02% or 1.01 million shares. The Texas-based Next Financial Grp has invested 0.03% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Nexus Investment Mgmt Incorporated reported 37,055 shares. Cambridge Advsr, Nebraska-based fund reported 12,625 shares. Aviva Plc has invested 0.02% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Brigade Capital Mngmt LP owns 300,000 shares or 0.35% of their US portfolio. Bnp Paribas Arbitrage Sa reported 0.01% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Moreover, First Republic Investment has 0.04% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). 88,136 are owned by Lpl Llc. Old Second Comml Bank Of Aurora invested in 0.01% or 1,100 shares. Perigon Wealth Mngmt holds 0% or 25 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.